{"data":[{"id":"CV-REQ-000010","slug":"understand-swab-compatibility","audit":"Are the study swabs the same as routine swabs?","title":"Understand swab compatibility","region":"United States","status":"Current","topics":["swab-sampling","recovery"],"section":"Direct surface sampling","summary":"Sampling materials and extraction solvents can influence analytical results.","document":"fda-cleaning-processes","evidence":["Consumable specification","blank results"],"reviewer":null,"revision":1,"authority":"fda","sourceUrl":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-guides/validation-cleaning-processes-793","reviewedAt":null,"editorialState":"draft","interpretation":"Include the consumables used on site in the study design."},{"id":"CV-REQ-000011","slug":"understand-the-rinse-result","audit":"What does a passing rinse result actually cover?","title":"Understand the rinse result","region":"United States","status":"Current","topics":["rinse-sampling","recovery"],"section":"Rinse samples","summary":"Rinse testing must meaningfully represent residues on equipment surfaces.","document":"fda-cleaning-processes","evidence":["Rinse coverage map","method rationale"],"reviewer":null,"revision":1,"authority":"fda","sourceUrl":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-guides/validation-cleaning-processes-793","reviewedAt":null,"editorialState":"draft","interpretation":"Record which surfaces a rinse reaches and which remain uncertain."},{"id":"CV-REQ-000017","slug":"establish-method-capability","audit":"Is a low result distinguishable from a method limitation?","title":"Establish method capability","region":"United States","status":"Current","topics":["analytical-methods","recovery"],"section":"12.7 — analytical methods","summary":"Analytical sensitivity and attainable recovery should support residue evaluation.","document":"ich-q7","evidence":["Validation report","recovery data"],"reviewer":null,"revision":1,"authority":"fda","sourceUrl":"https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q7a-good-manufacturing-practice-guidance-active-pharmaceutical-ingredients","reviewedAt":null,"editorialState":"draft","interpretation":"Read the laboratory result together with the method capability statement."}],"meta":{"total":3,"page":1,"per_page":20,"total_pages":1,"release":"preview-2026-09-16","filters":{"authority":"fda","topic":"recovery","q":"recovery"}}}